OrthoPediatrics (KIDS) Misses Q4 EPS by 2c, provides guidance

OrthoPediatrics (NASDAQ: KIDS) reported Q4 EPS of ($0.29), $0.02 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $37.61 million versus the consensus estimate of $37.73 million.

GUIDANCE:

OrthoPediatrics sees FY2024 revenue of $197-200 million, versus the consensus of $184.8 million, representing growth of 32% to 34% over 2023 revenue. The Company also expects its annual set deployment to be less than $20.0 million and expects to generate $8.0 million to $9.0 million of adjusted EBITDA for full year 2024.

For earnings history and earnings-related data on OrthoPediatrics (KIDS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c